1. Home
  2. HGBL vs CALC Comparison

HGBL vs CALC Comparison

Compare HGBL & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HGBL
  • CALC
  • Stock Information
  • Founded
  • HGBL 1937
  • CALC 2011
  • Country
  • HGBL United States
  • CALC United States
  • Employees
  • HGBL N/A
  • CALC N/A
  • Industry
  • HGBL Business Services
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • HGBL Consumer Discretionary
  • CALC Health Care
  • Exchange
  • HGBL Nasdaq
  • CALC Nasdaq
  • Market Cap
  • HGBL 51.1M
  • CALC 45.4M
  • IPO Year
  • HGBL N/A
  • CALC N/A
  • Fundamental
  • Price
  • HGBL $1.25
  • CALC $3.09
  • Analyst Decision
  • HGBL Strong Buy
  • CALC Strong Buy
  • Analyst Count
  • HGBL 1
  • CALC 2
  • Target Price
  • HGBL $4.00
  • CALC $14.50
  • AVG Volume (30 Days)
  • HGBL 100.9K
  • CALC 25.2K
  • Earning Date
  • HGBL 11-06-2025
  • CALC 11-12-2025
  • Dividend Yield
  • HGBL N/A
  • CALC N/A
  • EPS Growth
  • HGBL N/A
  • CALC N/A
  • EPS
  • HGBL 0.09
  • CALC N/A
  • Revenue
  • HGBL $49,890,000.00
  • CALC N/A
  • Revenue This Year
  • HGBL $20.86
  • CALC N/A
  • Revenue Next Year
  • HGBL $4.61
  • CALC N/A
  • P/E Ratio
  • HGBL $14.57
  • CALC N/A
  • Revenue Growth
  • HGBL 0.02
  • CALC N/A
  • 52 Week Low
  • HGBL $1.24
  • CALC $1.42
  • 52 Week High
  • HGBL $2.39
  • CALC $4.26
  • Technical
  • Relative Strength Index (RSI)
  • HGBL 26.09
  • CALC 49.22
  • Support Level
  • HGBL $1.25
  • CALC $2.95
  • Resistance Level
  • HGBL $1.50
  • CALC $3.39
  • Average True Range (ATR)
  • HGBL 0.07
  • CALC 0.15
  • MACD
  • HGBL -0.01
  • CALC 0.01
  • Stochastic Oscillator
  • HGBL 9.62
  • CALC 30.68

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: